5
Years Operating
2021 – 2026
$800K
Deployed to Research
5-yr cumulative
6
Countries Funded
Active grantees
$500K
Break Through Cancer
Defying Osteosarcoma TeamLab
2
White House Moonshot
2022 · 2023 invitations
Capital Deployed · 2021–2026
USA
NORWAY
UK
AUSTRIA
ITALY
VENEZUELA
Break Through Cancer · Defying Osteosarcoma TeamLab
8-institution US osteosarcoma research consortium · named partner
$500K
University of South Carolina · Prof. Nancy DeMore
Monoclonal antibody therapy for metastatic osteosarcoma · 50/50 co-funded with philanthropic partner · USA
$204K
Oslo University Hospital · Radiumhospitalet
Pediatric oncology research and teenager relax room funding · Norway
$54K +
Children's Cancer Research Institute Vienna · Dr. Wolfgang Paster
Immunotherapy targeting osteosarcoma · 50/50 co-funded with philanthropic partner · Austria
$12.6K
Additional research and patient support · UK, Italy, Venezuela
Childhood cancer research conference (Italy) · prosthesis funding and care-related needs (UK, Venezuela)
3 countries
Institutional Credibility
White House Cancer Moonshot
Invited to the Childhood Cancer Forum in 2022 (first such White House convening since 2016) and 2023.
Break Through Cancer · Named Partner
$500K committed to the Defying Osteosarcoma TeamLab · an 8-institution US research consortium:
Memorial Sloan Kettering · MD Anderson · Dana-Farber · Johns Hopkins Kimmel · Stanford · UCSF · Tufts · BC Cancer Research Institute
Bardo's proprietary global clinical trials platform · dedicated exclusively to osteosarcoma · trusted patient-facing information and a worldwide trial explorer for families and clinicians.
Financial Transparency
Candid Platinum Seal · the highest transparency tier · all financial and operational data publicly disclosed.
Operating Model
Lean operating structure · 30 years institutional finance experience at the helm · grant capital flows directly to researchers without a fundraising overhead layer.
Active in 2026
Defying Osteosarcoma TeamLab
$500K commitment to Break Through Cancer · 2025–2028 multi-year deployment · 8-institution US osteosarcoma research consortium.
Radiumhospitalet Training Room
Dedicated oncology patient training facility at Oslo's new Radiumhospitalet · ~$54K Bardo commitment · partnership with Oslo University Hospital · 2026 build.
Holmenkollstafetten · Four-Peat
Bardo Running Club · new charity-category record at Holmenkollstafetten each year 2023 · 2024 · 2025 · 2026 · four-peat secured 9 May 2026 · 100+ runners active across the club.